ImmunityBio reports $113 million revenue, 700% annual increase

Go back to ImmunityBio reports $113 million revenue, 700% annual increase
(NASDAQ: IBRX) Delayed: 7.18 -0.05 (0.69%)
Previous Close $7.23    52 Week High
Open $7.23    52 Week Low
Day High $7.30    P/E N/A 
Day Low $7.03    EPS
Volume 8,965,526